PRNewswire/ - MolecuLight today announced that its MolecuLightDX(R) wound measurement has been qualified by the U.S. Food and Drug Administration (FDA) as a Medical Device Development Tool (MDDT). The ...
Alps Dx and Hamilton Company today announced the showcase of Alps Dx Atelier, an automated system designed to streamline and standardize the preanalytical stage of oral fluid drug testing. This ...
HILDEN, Germany & GERMANTOWN, Md,--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAstat-Dx Viral Vesicular Panel RUO, the first syndromic ...
FDA Clearance Received Through Partnership with Grifols to Support Screening for Risk of Alpha 1 - Antripsyn Deficiency (Alpha-1) in U.S. Adult Population BETHLEHEM, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE ...
MolecuLight Platform is Becoming the Standard-of-Care for Real-Time Imaging of Elevated Bacterial Burden in Wounds Across All Wound Care Settings TORONTO, Oct. 14, 2021 /PRNewswire/ - MolecuLight Inc.
Clinicians Recently Performed the 100,000th Procedure Implanting an ICD Equipped with DX Technology – the World's Only Single-Lead ICD System Providing Direct Atrial Sensing BERLIN, Jan. 29, 2024 ...
MolecuLight today announced that its MolecuLightDX wound measurement has been qualified by the U.S. Food and Drug Administration (FDA) as a Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results